We dont believe in sacrificing safety for price, but thats exactly what youll be doing if you choose GLP-1 patches
1 Rubio M, et al
Pharmaceutical companies have been trying to produce small-molecule GLP-1 agonists that are shelf-stable and can be taken orallyfor instance, Pfizer and Eli Lilly have developed Danuglipron and Orforglipron, respectivelybut we know very little about how they work, said Ali Gler, a neuroscientist at the University of Virginia
To put this in perspective: if you weigh 200 pounds, tirzepatide helped people lose an average of 50.3 pounds, versus 33.1 pounds with semaglutide
However, this delayed emptying can contribute to feelings of fullness, bloating, and nauseaparticularly common when initiating therapy or increasing doses
Sustained adherence represents a major advantage: according to research from Northwestern Medicine, 50-75% of people who start taking standard-dose GLP-1 medications stop using them within a year
